rs11568819

This is a regulatory region variant variant in the MMP7 gene.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

matrix metalloproteinase 7 measurement

Allele A
OR 0.58
p 2.0e-222
N 21,758
Large GWAS
European

matrilysin measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele A
OR 0.64
p 2.0e-139
N 10,708
Large GWAS
European
Allele A
OR 0.72
p 9.0e-24
N 2,935
Large GWAS
Greater Middle Eastern (Middle Eastern, North African or Persian)
Allele A
OR 0.67
p 6.0e-14
N 997
Small GWAS
multi-ancestry

blood protein amount

Allele A
OR 0.50
p 6.0e-42
N 5,367
Large GWAS
European
Emilsson V et al. Co-regulatory networks of human serum proteins link genetics to disease. Science (new York, N.y.) 361(6404):769-773 (2018)
Allele A
OR 0.50
p 5.0e-21
N 3,200
Large GWAS
European

Research that mentions this SNP (2)

Association of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts
AssociationN=2,288Ariadne Letra et al.(2012)· Birth Defects Research Part A: Clinical and Molecular Teratology

Association study of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts in Brazilian case-control (494 cases, 413 controls) and US family-based (881 families) cohorts. MMP3 rs522616 showed strong association with all clefts (P=0.00002), cleft lip/palate (P=0.0009), and cleft palate (P=0.006). TIMP2 rs8179096 associated with all clefts (P=0.004), cleft lip/palate (P=0.01), and cleft palate (P=0.02). Significant gene-gene interaction between MMP3-TIMP2 detected (P=0.000001).

Traits studied:Cleft lipCleft lip and palateCleft palateNonsyndromic oral clefts
Genetic polymorphisms in the MMP‐7 gene and breast cancer survival
AssociationN=1,079Alicia Beeghly‐Fadiel et al.(2009)· International Journal of Cancer

This population-based survival study of 1,079 Chinese breast cancer patients found that two common MMP-7 polymorphisms significantly predict breast cancer prognosis. Patients homozygous for the rs11568818 rare allele (G) had substantially worse overall survival (HR: 6.7, 95% CI: 2.4-18.6), while rs11225297 T allele carriers showed improved survival in a dose-response manner (AT: HR 0.7; TT: HR 0.3).

Traits studied:Breast cancer prognosisBreast cancer survivalDisease-free survivalOverall survival

About MMP7

This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down proteoglycans, fibronectin, elastin and casein and differs from most MMP family members in that it lacks a conserved C-terminal hemopexin domain. The enzyme is involved in wound healing, and studies in mice suggest that it regulates the activity of defensins in intestinal mucosa. The gene is part of a cluster of MMP genes on chromosome 11. This gene exhibits elevated expression levels in multiple human cancers. [provided by RefSeq, Jan 2016]

View all MMP7 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…